|
JPS6037953A
(ja)
*
|
1983-08-11 |
1985-02-27 |
Herusu Eido:Kk |
カルシウムを主成分とする栄養補助食品
|
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
|
GB9402203D0
(en)
*
|
1994-02-04 |
1994-03-30 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
US6241983B1
(en)
|
1994-10-28 |
2001-06-05 |
Metagenics, Inc. |
Bacteria-and fiber-containing composition for human gastrointestinal health
|
|
US5531989A
(en)
|
1994-10-28 |
1996-07-02 |
Metagenics, Inc. |
Immunoglobulin and fiber-containing composition for human gastrointestinal health
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
ATE214597T1
(de)
|
1997-12-19 |
2002-04-15 |
Merck Patent Gmbh |
Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien
|
|
JP2000302694A
(ja)
|
1999-04-16 |
2000-10-31 |
Fuyuki Mitsuyama |
医食兼用物質
|
|
US6696057B1
(en)
|
1999-09-22 |
2004-02-24 |
Lacpro Industries, Inc. |
Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
|
|
US20020044926A1
(en)
|
1999-12-10 |
2002-04-18 |
Gregor Reid |
Oral administration of lactobacillus for the treatment and prevention of urogenital infection
|
|
US20030118547A1
(en)
*
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
DE60123384T2
(de)
|
2000-02-04 |
2007-08-02 |
DepoMed, Inc., Menlo Park |
Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
|
|
EP1151673A3
(en)
|
2000-05-03 |
2002-01-02 |
Societe Des Produits Nestle S.A. |
Confectionery product having a filling
|
|
KR20040018319A
(ko)
|
2000-12-18 |
2004-03-03 |
프로비오헬쓰 엘엘씨 |
락토바실러스 카제이 균주 κε01에서 유래된 정장제 화합물
|
|
AUPR272901A0
(en)
|
2001-01-25 |
2001-02-22 |
Gainful Plan Limited |
Method of preparing biological materials and preparations produced using same
|
|
EP1228769A1
(de)
|
2001-02-02 |
2002-08-07 |
Jörg-Peter Prof. Schür |
Symbiontisches Regenerativum
|
|
EP1392245A2
(en)
|
2001-04-05 |
2004-03-03 |
Universite Laval |
Process for making protein delivery matrix and uses thereof
|
|
US6627220B2
(en)
|
2001-07-13 |
2003-09-30 |
Scolr, Inc. |
Tablets containing heat sensitive materials and method for forming thereof
|
|
US8048924B2
(en)
|
2001-08-29 |
2011-11-01 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
|
EP1429802B1
(en)
*
|
2001-09-28 |
2012-11-07 |
TNTGamble, Inc. |
Delivery system for biological component
|
|
US20070098784A1
(en)
*
|
2001-09-28 |
2007-05-03 |
Nutraceutix, Inc. |
Delivery system for biological component
|
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
|
EP1344458A1
(en)
|
2002-03-12 |
2003-09-17 |
Société des Produits Nestlé S.A. |
Probiotic delivery system
|
|
US20030175295A1
(en)
|
2002-03-15 |
2003-09-18 |
Richard Ticktin |
Composition and method for reducing odors from metabolic processes
|
|
US7670612B2
(en)
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
TW200404544A
(en)
|
2002-06-17 |
2004-04-01 |
Kowa Co |
Controlled release pharmaceutical composition
|
|
US20050266069A1
(en)
|
2002-09-06 |
2005-12-01 |
Simmons Donald L |
Stable probiotic microsphere compositions and their methods of preparation
|
|
US8168170B2
(en)
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
|
US7105336B2
(en)
|
2002-10-07 |
2006-09-12 |
Biogaia Ab |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
|
|
CA2504610C
(en)
*
|
2002-11-12 |
2012-02-21 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
|
EP1607087A1
(en)
|
2003-03-27 |
2005-12-21 |
Hisamitsu Pharmaceutical Co., Inc. |
Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
|
|
US7025998B2
(en)
|
2003-05-30 |
2006-04-11 |
Rotta Research Laboratorium S.P.A. |
Phytoestrogens and probiotic for women's health
|
|
DE602004030922D1
(de)
|
2003-08-21 |
2011-02-17 |
Otsuka Pharma Co Ltd |
Milchsäurebakterien mit mucosa-immunpotenzierungseffekt
|
|
GB0330009D0
(en)
*
|
2003-12-24 |
2004-01-28 |
Ferrosan As |
Probiotic tablet formulations
|
|
WO2005074976A1
(en)
|
2004-02-09 |
2005-08-18 |
Transfert Plus Société En Commandite |
Composition comprising polymeric material and uses thereof
|
|
US20050260181A1
(en)
|
2004-03-05 |
2005-11-24 |
Immunopath Profile, Inc. |
Compositions and methods for tissue repair
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
GB0410785D0
(en)
|
2004-05-14 |
2004-06-16 |
Glycologic Ltd |
Improved prebiotic
|
|
WO2005115341A2
(en)
|
2004-05-27 |
2005-12-08 |
Advanced Bionutrition Corporation |
Microparticles for oral delivery
|
|
DE102004026706A1
(de)
|
2004-05-28 |
2005-12-15 |
Merck Patent Gmbh |
Orale Darreichungsform enthaltend probiotische Bakterien
|
|
US20060062773A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for maintaining and restoring normal gastrointestinal flora
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
JP5576606B2
(ja)
|
2005-05-18 |
2014-08-20 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
微生物の腸内投与用組成物
|
|
CA2623968C
(en)
|
2005-09-29 |
2014-12-09 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Method for stabilising pharmaceutical administration forms comprising microorganisms
|
|
US7982066B2
(en)
|
2005-12-09 |
2011-07-19 |
Novalife, Inc. |
High protein supplement
|
|
WO2007070052A2
(en)
|
2005-12-14 |
2007-06-21 |
Oxthera, Inc. |
Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
|
|
US20070184111A1
(en)
|
2006-02-03 |
2007-08-09 |
Pharmavite Llc |
Hybrid tablet
|
|
EP2117354B1
(en)
|
2006-12-18 |
2018-08-08 |
Advanced BioNutrition Corp. |
A dry food product containing live probiotic
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
US20080171085A1
(en)
|
2007-01-11 |
2008-07-17 |
Natrol, Inc. |
Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
|
|
US8066986B2
(en)
*
|
2007-02-01 |
2011-11-29 |
Master Supplements, Inc. |
Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms
|
|
ES2393814T3
(es)
|
2007-04-04 |
2012-12-28 |
Sigmoid Pharma Limited |
Una composición farmacéutica oral
|
|
WO2009020595A2
(en)
*
|
2007-08-03 |
2009-02-12 |
Shaklee Corporation |
Nutritional supplement system
|
|
US20100239682A1
(en)
|
2007-09-17 |
2010-09-23 |
Antoine Andremont |
Colonic delivery of antimicrobial agents
|
|
US9078824B2
(en)
|
2007-09-24 |
2015-07-14 |
The Procter & Gamble Company |
Composition and method of stabilized sensitive ingredient
|
|
US20110223248A1
(en)
|
2007-12-12 |
2011-09-15 |
Ritter Pharmaceuticals, Inc. |
Methods and compositions for treating lactose intolerance
|
|
KR20100120169A
(ko)
|
2008-01-24 |
2010-11-12 |
네스텍 소시에테아노님 |
영양 성분을 담고 있는 캡슐 및 이 캡슐로부터 영양액을 전달하는 방법
|
|
MX2010011995A
(es)
|
2008-05-01 |
2010-12-02 |
Procter & Gamble |
Metodos y estuches para el tratamiento de condiciones y trastornos inflamatorios del intestino.
|
|
WO2009149149A1
(en)
|
2008-06-04 |
2009-12-10 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
CN102123604A
(zh)
*
|
2008-06-24 |
2011-07-13 |
Wm.雷格利Jr.公司 |
益生菌口香糖的制造方法
|
|
CA2737247C
(en)
|
2008-09-15 |
2016-10-11 |
Labopharm Inc. |
Starch-based microparticles for the release of agents disposed therein
|
|
AU2009313867A1
(en)
*
|
2008-11-14 |
2011-06-30 |
Patheon Inc. |
Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low pH and methods of use thereof
|
|
GB0900551D0
(en)
|
2009-01-14 |
2009-02-11 |
Horton Richard |
Ingestible compositions and processes of preparation
|
|
SI2381799T1
(sl)
|
2009-01-27 |
2018-12-31 |
Probiotical S.P.A. |
Probiotični dodatek z okusom čokolade
|
|
EP2400839B1
(en)
|
2009-02-24 |
2016-09-07 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
ZA201107285B
(en)
|
2009-03-06 |
2012-12-27 |
Delivtx Inc |
Microencapsulated bioactive agents for oral delivery and methods of the thereof
|
|
WO2010105207A1
(en)
|
2009-03-13 |
2010-09-16 |
The Regents Of The University Of California |
Prebiotic oligosaccharides
|
|
US20100330151A1
(en)
|
2009-06-25 |
2010-12-30 |
Mary Elaine Freeland |
Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
|
|
WO2011009848A2
(en)
*
|
2009-07-20 |
2011-01-27 |
Bracco Spa |
Therapeutic use of probiotics
|
|
EP2459203B1
(en)
|
2009-07-30 |
2018-10-31 |
DuPont Nutrition Biosciences ApS |
Lactic acid bacteria and bifidobacteria for treating endotoxemia
|
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
|
AU2010339573B2
(en)
|
2009-12-31 |
2014-08-28 |
Ira Milton Trachtman |
Compositions and method for treatment and prophylaxis of inflammatory bowel disease
|
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
|
KR101143997B1
(ko)
|
2010-03-04 |
2012-05-09 |
한미사이언스 주식회사 |
유산균 제제 및 5-ｈｔ4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법
|
|
WO2011130487A1
(en)
|
2010-04-14 |
2011-10-20 |
Ganeden Biotech, Inc. |
Probiotic confection and lipid compositions
|
|
EP3202406A1
(en)
|
2010-04-28 |
2017-08-09 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
CN103221420A
(zh)
|
2010-05-19 |
2013-07-24 |
北卡罗莱纳州立大学 |
用于递送治疗性肽的组合物和方法
|
|
US20140154312A1
(en)
|
2010-09-17 |
2014-06-05 |
Monica Gulati |
Oral targetted drug delivery system
|
|
WO2012103411A2
(en)
*
|
2011-01-28 |
2012-08-02 |
Zx Pharma, Llc |
Controlled-release melatonin composition and related methods
|
|
JP2014508186A
(ja)
*
|
2011-03-17 |
2014-04-03 |
プロバイオティカル・ソシエタ・ペル・アチオニ |
抗酸化活性を有するプロバイオティクス細菌およびそれらの使用
|
|
WO2012154738A1
(en)
|
2011-05-09 |
2012-11-15 |
The Cleveland Clinic Foundation |
Composition and method to improve intestinal health
|
|
ES2660775T3
(es)
|
2011-05-16 |
2018-03-26 |
Belano Medical Ag |
Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
|
|
CN202427429U
(zh)
*
|
2012-01-09 |
2012-09-12 |
北京大北农科技集团股份有限公司 |
一种多层微囊制备设备
|
|
US20130295227A1
(en)
|
2012-05-01 |
2013-11-07 |
Robbert H. ter Haar |
Composition Comprising a Sensitive Ingredient
|
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
|
US20140112985A1
(en)
|
2012-10-22 |
2014-04-24 |
Polonez Therapeutics Llc |
Method of prevention and treatment of clostridium difficile infection
|
|
EP3536328B1
(en)
*
|
2013-02-22 |
2021-10-27 |
The Regents of The University of California |
Food or beverage product, or probiotic composition, comprising lactobacillus johnsonii 456
|
|
AU2014239883B2
(en)
*
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|